Wall Street Analysts Think Atara Biotherapeutics (ATRA) Could Surge 33.03%: Read This Before Placing a Bet
Portfolio Pulse from
Wall Street analysts suggest a potential 33% upside for Atara Biotherapeutics (ATRA) based on consensus price targets. Despite skepticism about the effectiveness of price targets, positive earnings estimate revisions could indicate a near-term stock price increase.
February 14, 2025 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts predict a 33% upside for Atara Biotherapeutics (ATRA) based on consensus price targets. Positive earnings estimate revisions suggest potential near-term gains.
The article highlights a 33% upside potential for ATRA based on analyst price targets. While price targets alone may not be reliable, the upward trend in earnings estimate revisions provides a stronger basis for expecting a near-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100